Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease

Update on FDA Advisory Committee’s Meeting on Aducanumab in Alzheimer’s Disease

CAMBRIDGE, Mass. and TOKYO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Today, the U.S. Food and Drug Adm...
read more
Serendipitous meeting leads to new insights into Fanconi anemia

Serendipitous meeting leads to new insights into Fanconi anemia

A chance exchange between Yale scientists has led ...
read more